2.210
2.21 (0%)
As of Dec 24, 2024
Lexaria Bioscience Corp. [LEXX]
Source:
Company Overview
Lexaria Bioscience Corp. is a biotechnology company dedicated to the enhancement of the bioavailability of a broad range of active pharmaceutical ingredients (“APIs”) using our patented DehydraTECHTM drug delivery-enabling platform technology
| Country | United States |
| Headquarters | kelowna |
| Phone Number | 250-765-6424 |
| Industry | manufacturing |
| CEO | Richard Christopher |
| Website | www.cdc.gov |